Decreasing expression of the G1-phase inhibitors, p21Cip1 and p16ink4a, promotes division of corneal endothelial cells from older donors

Molecular Vision

Volumn 16, Issue , 2010, Pages 897-906

  Joyce, Nancy C ^a   Harris, Deshea L ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; SMALL INTERFERING RNA; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL DENSITY; CELL DIVISION; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DOWN REGULATION; ELECTROPORATION; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; ADULT; AGED; AGING; CELL CYCLE G1 PHASE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AGING; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; ELECTROPORATION; ENDOTHELIAL CELLS; ENDOTHELIUM, CORNEAL; G1 PHASE; HUMANS; MIDDLE AGED; RNA, SMALL INTERFERING;

EID: 77955605188     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Murphy C, Alvarado J, Juster R, Maglio M. Prenatal and postnatal cellularity of the human corneal endothelium. Invest Ophthalmol Vis Sci 1984; 25:312-22.
2. Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci 2000; 41:660-6.
3. Senoo T, Obara Y, Joyce NC. EDTA: A promoter of proliferation in human corneal endothelium. Invest Ophthalmol Vis Sci 2000; 41:2930-5.
4. Patel SP, Bourne WM. Corneal endothelial cell proliferation: a function of cell density. Invest Ophthalmol Vis Sci 2009; 50:2742-6.
5. Chen K-H, Azar D, Joyce NC. Transplantation of adult human corneal endothelium ex vivo. Cornea 2001; 20:731-7.
6. Zhu C, Joyce NC. Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci 2004; 45:1743-51.
7. Joyce NC, Meklir B, Joyce SJ, Zieske J. Cell cycle protein expression and proliferative status in human corneal cells. Invest Ophthalmol Vis Sci 1996; 37:645-55.
8. Joyce NC, Navon SE, Roy S, Zieske J. Expression of cell cycleassociated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci 1996; 37:1566-75.
9. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997; 94:7245-50.
10. Harper JW, Adami GF, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1-cyclin-dependent kinases. Cell 1993; 75:805-16.
11. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massagué J. Cloning of p27Kip1, a cyclindependent protein kinase inhibitor and a potential mediator of extracellular anti-mitogenic signals. Cell 1994; 78:59-66.
12. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Retinoblastoma-protein-dependent cellcycle inhibition by the tumour suppressor p16. Nature 1995; 375:503-6.
13. Coats S, Flanagan WM, Nourse J, Roberts JM. Requirements of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272:877-80.
14. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994; 8:9-22.
15. El-Deiry WS, Tokino VE, Velculescu DB, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-25.
16. Gartel AL, Tyner AL. Transcriptional regulation of the p21(WAF1/CIP1) gene. Exp Cell Res 1999; 246:280-9.
17. Dai CY, Enders GH. P16INK4a can initiate an autonomous senescence program. Oncogene 2000; 19:1613-22.
18. McConnell BB, Starborg M, Brookes S, Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol 1998; 8:351-4.
19. Kato D, Miyazawa K, Ruas M, Starborg M, Wada I, Oka T, Sakai T, Peters G, Hara E. Features of replicative senescence induced by direct addition of antennapedia p16INK4A fusion protein to human diploid fibroblasts. FEBS Lett 1998; 427:203-8.
20. Nylandsted J, Rohde M, Bartek J, Strauss M. Expression of a p16INK4a-specific ribozyme downmodulates p16INK4a abundance and accelerates cell proliferation. FEBS Lett 1998; 436:41-5.
21. Zhou HW, Lou SQ, Zhang K. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro. Rheumatology (Oxford) 2004; 43:555-68.
22. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82:675-84.
23. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277:831-4.
24. Joyce NC, Harris DL, Zieske JD. Mitotic inhibition of corneal endothelium in neonatal rats. Invest Ophthalmol Vis Sci 1998; 39:2572-83.
25. Enomoto K, Mimura T, Harris DL, Joyce NC. Age-related differences in cyclin-dependent kinase inhibitor expression and retinoblastoma hyperphosphorylation in human corneal endothelial cells. Invest Ophthalmol Vis Sci 2006; 47:4330-40.
26. Kikuchi M, Zhu C, Senoo T, Obara Y, Joyce NC. p27kip1 siRNA induces age-dependent proliferation of human corneal endothelial cells. Invest Ophthalmol Vis Sci 2006; 47:4803-9.
27. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD. Immunobiochemical and molecular biologic characterization of the cell-proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991; 138:867-73.
28. Engler C, Kelliher C, Wahlin KJ, Speck CL, Jun AS. Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells. Mol Vis 2009; 15:629-37.
29. Bednarz J, Teifel M, Friedl P, Engelmann K. Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human pigment epithelial cells. Acta Ophthalmol Scand 2000; 78:130-6.
30. Wilson SE, Weng J, Blair S, He YG, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated highproliferative capacity. Invest Ophthalmol Vis Sci 1995; 36:32-40.
31. He Z, Pipparelli A, Manissolle C, Acquart S, Garraud O, Gain P, Thuret G. Ex vivo gene electrotransfer to the endothelium of organ cultured human corneas. Ophthalmic Res 2009; 43:43-55.
32. Oshima Y, Sakamoto T, Yamanaka I, Nishi T, Ishibashi T, Inomata H. Targeted gene transfer to corneal endothelium in vivo by electric pulse. Gene Ther 1998; 5:1347-54.
33. Joyce NC, Zhu CC. Human corneal endothelial cell proliferation: Potential for use in regenerative medicine. Cornea 2004; 23:S8-19.